Table 1: Clinical characteristics.
CP (n = 24) | DP (n = 91) | P value | |
---|---|---|---|
Median age (years) | 54 (31-79) | 57 (19-78) | 0.4285a |
Gender, no, (%) | 0.2137b | ||
Male | 5 (21) | 31 (34) | |
Female | 19 (79) | 60 (66) | |
Average height (cm) | 158.8 (140-175) | 159.6 (138.4-180) | 0.6861c |
Average body weight size (kg) | 55.9 (38-89.3) | 57.2 (35.2-88.1) | 0.6358c |
Average body mass index (Kg/m2) | 22.1 (16.2-31.8) | 22.3 (15.0-33.1) | 0.8131c |
Average serum albumin level (g/di) | 4.3 (3.3-5.1) | 4.3 (3.5-4.9) | 0.7321c |
Average serum HbA1c level (NGSP), (%) | 5.6 (4.3-9.8) | 5.9 (4-8.7) | 0.0840c |
Average follow up period (years) | 5.64 (1.83-11.03) | 4.79 (1.08-10.68) | 0.1467c |
Primary disease, no, (%) | 0.2998b | ||
IPMN | 9 (38) | 42 (46) | |
NET | 9 (38) | 20 (22) | |
SPN | 3 (13) | 13 (14) | |
MCN | 1 (4) | 14 (15) | |
Pancreatic cancer | 1 (4) | 1 (1) | |
Other | 1 (4) | 1 (1) |
IPMN: Intraductal Papillary Mucinous Neoplasm; NET: Neuroendocrine Tumor; SPN: Solid Pseudopapillary Neoplasm; MCN: Mucinous Cystic Neoplasm; aWilcoxon Test; bχ2 Test; cT-Test.